OPGN - オプジェン (OpGen Inc.) オプジェン

 OPGNのチャート


 OPGNの企業情報

symbol OPGN
会社名 OpGen Inc (オプジェン)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Specialities  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オプジェン(OpGen Inc.)は生命科学のための光学的マッピングソリューションの提供に従事する米国の会社である。同社は微生物、酵母、及び真菌ゲノムアーキテクチャの分析ため光学的マッピングサービスを提供する。その光学的マッピング技術は、生命科学、臨床的及び食品微生物学、生命科学、疫学、薬理学、微生物法医学、製造品質管理、及び応用研究アプリケーションに応用される。同社のマップ解析ソフトウェアモジュールは、100Mb以内の微生物サンプルとゲノムため分析を提供する「Argus」全ゲノムマッピングシステムを含む。   オプジェンは、米国のバイオ企業。医療提供者を支援するために、分子テストや生物情報学を用いて、多剤抵抗性細菌感染症向けに初期商用段階の医薬品を提供。また、全遺伝子解読のための製品やサ―ビスを提供するほか、生命科学のための微生物、植物、動物およびヒト遺伝子の分析を手掛ける。   OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
本社所在地 708 Quince Orchard Road Suite 160 Gaithersburg MD 20878 USA
代表者氏名 Evan Jones エヴァンジョーンズ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 240-813-1260
設立年月日 36892
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数
url www.opgen.com
nasdaq_url https://www.nasdaq.com/symbol/opgn
adr_tso
EBITDA EBITDA(百万ドル) -11.73453
終値(lastsale) 1.9899
時価総額(marketcap) 12359820.1023
時価総額 時価総額(百万ドル) 8.57156
売上高 売上高(百万ドル) 3.37115
企業価値(EV) 企業価値(EV)(百万ドル) 3.09665
当期純利益 当期純利益(百万ドル) -12.61360
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 OpGen Inc revenues increased 11% to $1.6M. Net loss decreased 31% to $6.4M. Revenues reflect Collaboration revenue increase from $27K to $359K. Lower net loss reflects Interest and other income increase from $0K to $5K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$5.67 to -$1.32.

 OPGNのテクニカル分析


 OPGNのニュース

   Mid-Day Market Update: Crude Oil Down 1%; OpGen Shares Spike Higher  2020/08/20 12:22:00 Benzinga
Midway through trading Thursday, the Dow traded up 0.03% to 27702.48 while the NASDAQ rose 0.74% to 11,229.31. The S&P also rose, gaining 0.18% to …
   OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update  2020/08/12 20:05:00 GlobeNewswire
Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020Strategic…
   Thinking about buying stock in BioNano Genomics, Conduent Inc, OpGen Inc, Uber Technologies, or MGM Resorts?  2020/08/07 15:36:00 PR Newswire
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, CNDT, OPGN, UBER, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   OpGen : Corporate Presentation (PDF) | MarketScreener  2020/07/07 12:39:18 MarketScreener
OpGen Corporate Overview July 2020 Forward looking statements disclaimer This presentation… | July 7, 2020
   OpGen (OPGN) Stock Skyrockets 128% on Rapid Coronavirus Test Kit News  2020/03/16 18:52:36 InvestorPlace
OpGen (OPGN) news for Monday includes OPGN stock taking off following an update on test kits for the coronavirus from China.
   Mid-Day Market Update: Crude Oil Down 1%; OpGen Shares Spike Higher  2020/08/20 12:22:00 Benzinga
Midway through trading Thursday, the Dow traded up 0.03% to 27702.48 while the NASDAQ rose 0.74% to 11,229.31. The S&P also rose, gaining 0.18% to …
   OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update  2020/08/12 20:05:00 GlobeNewswire
Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020Strategic…
   Thinking about buying stock in BioNano Genomics, Conduent Inc, OpGen Inc, Uber Technologies, or MGM Resorts?  2020/08/07 15:36:00 PR Newswire
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, CNDT, OPGN, UBER, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   OpGen : Corporate Presentation (PDF) | MarketScreener  2020/07/07 12:39:18 MarketScreener
OpGen Corporate Overview July 2020 Forward looking statements disclaimer This presentation… | July 7, 2020
   OpGen (OPGN) Stock Skyrockets 128% on Rapid Coronavirus Test Kit News  2020/03/16 18:52:36 InvestorPlace
OpGen (OPGN) news for Monday includes OPGN stock taking off following an update on test kits for the coronavirus from China.
   OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update  2020/08/12 20:05:00 GlobeNewswire
Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020Strategic…
   Thinking about buying stock in BioNano Genomics, Conduent Inc, OpGen Inc, Uber Technologies, or MGM Resorts?  2020/08/07 15:36:00 PR Newswire
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, CNDT, OPGN, UBER, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   OpGen : Corporate Presentation (PDF) | MarketScreener  2020/07/07 12:39:18 MarketScreener
OpGen Corporate Overview July 2020 Forward looking statements disclaimer This presentation… | July 7, 2020
   OpGen (OPGN) Stock Skyrockets 128% on Rapid Coronavirus Test Kit News  2020/03/16 18:52:36 InvestorPlace
OpGen (OPGN) news for Monday includes OPGN stock taking off following an update on test kits for the coronavirus from China.
   Nano-Cap OpGen Skyrockets On COVID-19 Connection  2020/03/16 17:49:06 Benzinga
OpGen Inc (NASDAQ: OPGN ) shares were ripping higher Monday in reaction to an announcement regarding a COVID-19 test kit from German molecular diagnostics company Curetis, which OpGen has agreed to merge with. Curetis said it has begun offering a CE-IVD-certified real-time PCR test kit for SARS-CoV-2, the virus causing COVID-19, OpGen said. The test kit, developed and manufactured by Curetis' Chinese strategic partner BGI, was cleared by the Chinese authorities in January. It was CE-IVD certified on Feb. 28. CE certification indicates … Full story available on Benzinga.com

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オプジェン OPGN OpGen Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)